|
⚲
|
| Keyboard |
| Noonberg Sarah B
✚
|
|
|---|---|
| CIK # | 0001706301 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001706301] | |
| 4 | [0001706301] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aquinox Pharmaceuticals Inc | |
| Noonberg Sarah B | |
| Metagenomi Therapeutics Inc | |
| Marinus Pharmaceuticals Inc | |
| Protagonist Therapeutics Inc | |
| Prothena Corp Public Ltd Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aquinox Pharmaceuticals Inc NGNE
Non-Qualified Stock Option (right to buy) · derivative
|
2026-02-20 | Grant | 12,050 | $0.00 | |
|
Aquinox Pharmaceuticals Inc NGNE
Non-Qualified Stock Option (right to buy) · derivative
|
2025-06-12 | Grant | 12,050 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-06-06 | Sell | 5,239 | $1.75 | 9,168 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-04-01 | Grant | 14,000 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Stock Option (Right to Buy) · derivative
|
2025-04-01 | Grant | 84,000 | $0.00 | |
|
Marinus Pharmaceuticals Inc MRNS
Common Stock
|
2024-06-18 | Grant | 2,300 | $0.00 | |
|
Marinus Pharmaceuticals Inc MRNS
Stock Option (Right to Buy) · derivative
|
2024-06-18 | Grant | 10,450 | $0.00 | |
|
Aquinox Pharmaceuticals Inc NGNE
Stock Option (Right to Buy) · derivative
|
2024-06-14 | Grant | 7,700 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2024-04-01 | Grant | 57,763 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Stock Option (Right to Buy) · derivative
|
2024-04-01 | Grant | 242,875 | $0.00 | |
|
Marinus Pharmaceuticals Inc MRNS
Common Stock
|
2024-01-18 | Grant | 4,600 | $0.00 | |
|
Marinus Pharmaceuticals Inc MRNS
Stock Option (Right to Buy) · derivative
|
2024-01-18 | Grant | 20,900 | $0.00 | |
|
Aquinox Pharmaceuticals Inc NGNE
Stock Option (Right to Buy) · derivative
|
2024-01-16 | Grant | 15,400 | $0.00 | |
|
Aquinox Pharmaceuticals Inc NLTX
Stock Option (Right to Buy) · derivative
|
2023-06-08 | Grant | 25,000 | $0.00 | |
|
Marinus Pharmaceuticals Inc MRNS
Common Stock
|
2023-05-16 | Grant | 7,200 | $0.00 | |
|
Marinus Pharmaceuticals Inc MRNS
Stock Option (Right to Buy) · derivative
|
2023-05-16 | Grant | 32,400 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2023-01-16 | Grant | 30,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2022-05-26 | Grant | 20,000 | $0.00 | |
|
Aquinox Pharmaceuticals Inc NLTX
Stock Option (Right to Buy) · derivative
|
2022-05-12 | Grant | 25,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2021-05-27 | Grant | 18,000 | $0.00 | |
| showing 20 of 35 most recent transactions | |||||